MR编号 | SE/H/0415/001 |
---|
药品名称 | Duodopa |
---|
活性成分 | - Carbidopa 5.0 mg/ml
- levodopa 20.0 mg/ml
|
---|
剂型 | Intestinal gel |
---|
上市许可持有人 | AbbVie AB
Sweden |
---|
参考成员国 - 产品名称 | Sweden (SE) |
---|
互认成员国 - 产品名称 | - Bulgaria (BG)
Duodopa - Croatia (HR)
- Romania (RO)
DUODOPA 20 mg/ml + 5 mg/ml gel intestinal - Germany (DE)
- Denmark (DK)
- Slovenia (SI)
- Belgium (BE)
- Netherlands (NL)
- Luxembourg (LU)
- Iceland (IS)
- United Kingdom (Northern Ireland) (XI)
- Ireland (IE)
- Liechtenstein (LI)
- Austria (AT)
Duodopa, 20 mg/ml + 5 mg/ml, Gel zur intestinalen Anwendung - France (FR)
- Spain (ES)
DUODOPA GEL INTESTINAL - Portugal (PT)
- Italy (IT)
- Greece (GR)
- Norway (NO)
- Finland (FI)
- Poland (PL)
Duodopa - Latvia (LV)
Duodopa intestināls gels - Lithuania (LT)
Duodopa 20/5mg/ml žarnyno gelis - Estonia (EE)
Duodopa - Hungary (HU)
Duodopa gél bélben történő alkalmazásra - Cyprus (CY)
DUODOPA INTESTINAL GEL - Czechia (CZ)
- Slovakia (SK)
|
---|
许可日期 | 2004/06/08 |
---|
最近更新日期 | 2024/10/10 |
---|
药物ATC编码 | - N04BA02 levodopa and decarboxylase inhibitor
|
---|
申请类型 | - TypeLevel1:Known Active Substance
- TypeLevel2:Initial Application
- TypeLevel3:Full Dossier Article 4.8 Di 65/65
- TypeLevel4:Chemical Substance
- TypeLevel5:Prescription Only
|
---|
附件文件下载 | |
---|
市场状态 | Positive |
---|